Epic Pharmacy

Broad-spectrum antibiotic effective against common pediatric respiratory and soft‑tissue pathogens: Streptococcus pneumoniae, H. influenzae (including resistant strains), Mycoplasma pneumoniae, Chlamydia pneumoniae, S. pyogenes, Moraxella catarrhalis 

Short-course, once‑daily dosing improves compliance in children 

Rapid symptom resolution: clinical improvement seen in ~89 % within 3 days; overall effectiveness ~95 % 

Well tolerated with generally mild and infrequent adverse reactions (mainly gastrointestinal)

Has anti‑inflammatory and immunomodulatory effects, which may aid in reducing respiratory inflammation Demonstrated reduction in respiratory hospitalization duration in vulnerable pediatric populations (e.g., children with Down syndrome)